Cost-Effectiveness of Ranibizumab Verse Aflibercept in Treatment of Treatment of Visual Impairment Due to Diabetic Macular Oedema (Dmo)

Value Health. 2014 Nov;17(7):A609. doi: 10.1016/j.jval.2014.08.2132. Epub 2014 Oct 26.

Authors

J Haig¹, S A Regnier², W Malcom³, W Xue⁴

Affiliations

¹ Optum, Burlington, ON, Canada.
² Novartis AG, Basel, Switzerland.
³ Novartis UK LTD, Frimley/Camberley, Surrey, UK.
⁴ Optum, Uxbridge, UK.

PMID: 27202123
DOI: 10.1016/j.jval.2014.08.2132

No abstract available